| abstract |
The present invention relates to a Neisseria ORF 2086 protein, a cross-reactive immunogenic protein (including its immunogenic portion, its biological equivalent), which can be isolated or recombinantly prepared from a Neisseria strain, Antibodies that specifically bind and nucleic acid sequences encoding each of the foregoing, and the use of the above in an immunogenic composition effective against infection by Neisseria meningitidis serogroup B. |